Article
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
Parkinsonism & related disorders - 1 Aug 2016
Mengel David, Dams Judith, Ziemek Jannis, Becker Julian, Balzer-Geldsetzer Monika, Hilker Rüdiger, Baudrexel Simon, Kalbe Elke, Schmidt Nele, Witt Karsten, Liepelt-Scarfone Inga, Gräber Susanne, Petrelli Annette, Neuser Petra, Schulte Claudia, Linse Katharina, Storch Alexander, Wittchen Hans-Ulrich, Riedel Oliver, Mollenhauer Brit, Ebentheuer Jens, Trenkwalder Claudia, Klockgether Thomas, Spottke Annika, Wüllner Ullrich, Schulz Jörg B, Reetz Kathrin, Heber Ines Ann, Ramirez Alfredo, Dodel Richard
Abstract excerpt
INTRODUCTION: Cognitive impairment is a common and disabling non-motor symptom in Parkinson's disease (PD). The apolipoprotein E (APOE) allele ε4 is a known risk factor for Alzheimer's disease and has also been suggested to be a risk factor for dementia in PD and even a predictor of impairment in certain cognitive domains. METHODS: A total of 447 PD patients (PD patients without cognitive impairment: n = 187; PD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
